Published 1 year ago

Group changes strategy after billion-dollar flop

Summary by Handelsblatt

After a billion-dollar flop, Nestlé is changing its strategy in one sector. The Aimmune Therapeutics takeover has missed expectations: No new acquisitions in the pharmaceutical sector, plans Nestlé CEO Mark Schneider.

0 Articles

All

Left

Center

Right

Handelsblatt

Group changes strategy after billion-dollar flop

1 year ago·Düsseldorf, Germany

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 year agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Group changes strategy after billion-dollar flop

0 Articles

0 Articles

Group changes strategy after billion-dollar flop

Group changes strategy after billion-dollar flop

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics